Skip to main content
رجوع
Watch Compare

STRATA Skin Sciences, Inc.

جودة البيانات: 100%
SSKN
OTC Manufacturing Measuring & Analyzing Instruments
KWD 0.17
▼ KWD 0.03 (-15.00%)
القيمة السوقية: 1.00 M
السعر
KWD 0.17
القيمة السوقية
1.00 M
نطاق اليوم
KWD 0.17 — KWD 0.17
نطاق 52 أسبوعًا
KWD 0.12 — KWD 3.86
حجم التداول
117
فتح KWD 0.17
متوسط 50 يوم / 200 يوم
KWD 0.52
67.22% below
متوسط 50 يوم / 200 يوم
KWD 1.45
88.29% below

Quick Summary

النقاط الرئيسية

Revenue grew 0.59% annually over 5 years — modest growth
Debt/Equity of 11.65 — high leverage
Negative free cash flow of -4.26 M
Revenue growth is decelerating — 1Y growth trails 5Y average by 9.13%
Capital efficient — spends only 4.78% of revenue on capex

النمو

Revenue Growth (5Y)
0.59%
أقل من متوسط القطاع (1.82%)
Revenue (1Y)-8.54%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

الجودة

Return on Equity
-772.01%
أقل من متوسط القطاع (-53.41%)
ROIC-22.92%
Net Margin-20.40%
Op. Margin-15.31%

الأمان

Debt / Equity
11.65
أعلى من متوسط القطاع (0.31)
Current Ratio0.95
Interest Coverage-2.40

التقييم

PE (TTM)
-0.16
أعلى من متوسط القطاع (-1.48)
P/B Ratio0.76
EV/EBITDAN/A
Dividend YieldN/A

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Manufacturing (1364 نظير)
المقياس السهم وسيط القطاع
P/E -0.2 -1.5
P/B 0.8 1.6
ROE % -772.0 -53.4
Net Margin % -20.4 -41.5
Rev Growth 5Y % 0.6 1.8
D/E 11.7 0.3

All Fundamental Metrics
Growth
Revenue Growth (1Y) -8.54% Revenue Growth (3Y) -4.07%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 0.59% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 30.70 M Net Income (TTM) -6.26 M
ROE -772.01% ROA -20.38%
Gross Margin 58.25% Operating Margin -15.31%
Net Margin -20.40% Free Cash Flow (TTM) -4.26 M
ROIC -22.92% FCF Growth (3Y) N/A
Safety
Debt / Equity 11.65 Current Ratio 0.95
Interest Coverage -2.40 Asset Turnover 1.00
Working Capital -761,000 Tangible Book Value -4.34 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0.16 Forward P/E N/A
P/B Ratio 0.76 P/S Ratio 0.03
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -425.53%
Market Cap 1.00 M Enterprise Value 9.24 M
Per Share
EPS (Diluted TTM) -1.35 Revenue / Share 5.21
FCF / Share -0.72 OCF / Share -0.47
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 4.78% FCF Conversion 68.07%
SBC-Adj. FCF -4.76 M Growth Momentum -9.13

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 30.70 M 33.56 M 33.36 M 36.16 M 29.98 M
Net Income -6.26 M -10.09 M -10.83 M -5.55 M -2.71 M
EPS (Diluted) -1.35 -2.65 -0.31 — —
Gross Profit 17.88 M 19.08 M 18.46 M 21.77 M 19.85 M
Operating Income -4.70 M -9.26 M -8.60 M -4.65 M -4.40 M
EBITDA — — — — —
R&D Expenses 421,000.0 883,000.0 1.32 M 1.03 M 1.43 M
SG&A Expenses — — — — —
D&A 4.12 M 4.97 M 5.55 M 2.40 M 2.10 M
Interest Expense 1.96 M 2.11 M 1.64 M 926,000.0 314,000.0
Income Tax 12,000.0 -170,000.0 -92,000.0 63,000.0 34,000.0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 30.52 M 36.16 M 42.02 M 52.27 M 46.59 M
Total Liabilities 27.61 M 31.19 M 29.33 M 30.44 M 21.18 M
Shareholders' Equity 2.91 M 4.97 M 12.69 M 21.83 M 25.41 M
Total Debt 15.35 M 15.00 M 15.00 M 8.00 M 8.00 M
Cash & Equivalents 7.91 M 7.26 M 6.78 M 5.43 M 12.59 M
Current Assets 15.60 M 16.60 M 15.54 M 17.50 M 19.97 M
Current Liabilities 26.74 M 14.63 M 12.17 M 13.43 M 12.80 M